US Medical Devices Ishares ETF (IHI)

Edwards Lifesciences has notably outperformed the broader market over the past year, and analysts remain bullish on the stock’s prospects.

Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Insulet has outperformed the broader market over the past year, and analysts remain strongly bullish on the company’s trajectory.

ResMed has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Despite Stryker’s underperformance relative to the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Zimmer Biomet has significantly underperformed the broader market and other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.

Although GE HealthCare stock has lagged behind the broader market over the past year, analysts remain moderately bullish about its prospects.

STERIS has outpaced its industry peers over the past year, and analysts are reasonably bullish on its future prospects.

DexCom has outperformed the broader medical devices industry over the past year, and analysts remain strongly bullish on the stock’s prospects.

Although Abbott Laboratories has underperformed its industry peers recently, analysts remain highly optimistic about the stock’s prospects.